Attorneys Investigating Eliquis Lawsuits Over Serious Bleeding Risks

March 20, 2015

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Anyone who suffered a serious bleeding complication after taking Eliquis (apixaban).
What Is Eliquis?
Eliquis, also known as apixaban, is an anticoagulant drug that is prescribed to reduce the risk of strokes and blood clots in people with atrial fibrillation and to treat blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism), especially following knee or hip replacement surgery. It belongs to the same group of drugs as Pradaxa and Xarelto.
What's The Problem?
Similar to popular anticoagulants Pradaxa and Xarelto, there is no antidote to stop the blood-thinning effects of Eliquis. Therefore, it is believed that Eliquis patients may be at risk for serious and fatal internal bleeding complications because doctors may be unable to treat and stabilize these patients in the event of a bleeding event.
What Can I Do?
If you or a loved one suffered a bleeding complication after taking Eliquis, attorneys would like to hear from you. Fill out the form on the right to get in touch with us today. You may be able to file a lawsuit against the maker of the drug and recover compensation for medical bills and other damages.